BioStock have interviewed CEO Hanna Sjöström to get to know more about the ongoing clinical study with the Neola®-device at University College Cork, Ireland, where the recruitment of 100 babies is completed. In the interview, the upcoming rights issue is also discussed.
See the entire interview (in Swedish) här.